Stock Earnings

Question 1

What are Novavax Inc's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Novavax Inc has a total asset of $1,560, Net loss of $-187

Question 2

What are the key financial ratios for NVAX?

Accepted Answer

Novavax Inc's Current ratio is 0.71, has a Net margin is -27.41, sales per share of $4.48.

Question 3

How is Novavax Inc's revenue broken down by segment or geography?

Accepted Answer

Novavax Inc largest revenue segment is Innovative Vaccines, at a revenue of 190,212,000 in the most earnings release.For geography, Europe is the primary market for Novavax Inc, at a revenue of 93,270,000.

Question 4

Is Novavax Inc profitable?

Accepted Answer

no, according to the latest financial statements, Novavax Inc has a net loss of $-187

Question 5

Does Novavax Inc have any liabilities?

Accepted Answer

yes, Novavax Inc has liability of 2,184

Question 6

How many outstanding shares for Novavax Inc?

Accepted Answer

Novavax Inc has a total outstanding shares of 160

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	1,064	682	983	1,981	1,146	475
Revenue Growth (YoY)	20%	-31%	-50%	73%	141%	2,539%
Cost of Revenue	87	201	343	902	--	--
Gross Profit	977	480	640	1,079	--	--
Selling, General & Admin	193	323	457	488	298	145
Research & Development	367	388	735	1,235	2,534	747
Operating Expenses	560	712	1,192	1,724	2,832	892
Other Non Operating Income (Expenses)	96	40	37	11	-1	12
Pretax Income	350	-176	-543	-653	-1,714	-418
Income Tax Expense	8	10	2	4	29	--
Net Income	341	-187	-545	-657	-1,743	-418
Net Income Growth	-220%	-66%	-17%	-62%	317%	217%
Shares Outstanding (Diluted)	162.35	152.19	100.76	78.2	74.4	57.6
Shares Change (YoY)	1%	51%	28.99%	5%	28.99%	139%
EPS (Diluted)	2.1	-1.23	-5.4	-8.42	-23.44	-7.27
EPS Growth	-219%	-77%	-36%	-64%	222%	32%
Free Cash Flow	-383	-100	-767	-508	265	-97
Free Cash Flow Per Share	-2.35	-0.65	-7.61	-6.49	3.56	-1.68
Gross Margin	91.82%	70.38%	65.1%	54.46%	--	--
Operating Margin	39.09%	-33.87%	-56.15%	-32.5%	-147.12%	-87.57%
Profit Margin	32.04%	-27.41%	-55.44%	-33.16%	-152.09%	-88%
Free Cash Flow Margin	-35.99%	-14.66%	-78.02%	-25.64%	23.12%	-20.42%
EBITDA	451	-183	-511	-615	-1,674	-412
EBITDA Margin	42.38%	-26.83%	-51.98%	-31.04%	-146.07%	-86.73%
D&A For EBITDA	35	48	41	29	12	4
EBIT	416	-231	-552	-644	-1,686	-416
EBIT Margin	39.09%	-33.87%	-56.15%	-32.5%	-147.12%	-87.57%
Effective Tax Rate	2.28%	-5.68%	-0.36%	-0.61%	-1.69%	--

Novavax Inc (NVAX) Price

NVAX Stock Price Chart

NVAX Income

Follow-Up Questions